Home
Suven Life Sciences Ltd PE Ratio

Suven Life Sciences Ltd
NSE: SUVEN
PE
Key Highlights
- The P/E Ratio of Suven Life Sciences Ltd is 0 as of 22 Feb 12:02 PM .
- The P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
- The Latest Trading Price of Suven Life Sciences Ltd is ₹ 117.45 as of 21 Feb 15:30 .
- The PE Ratio of Healthcare Industry has changed from 35.5 to 62.3 in 5 years. This represents a CAGR of 11.91%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of Healthcare industry is 62.3. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Suven Life Sciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Suven Life Sciences Ltd
Company Fundamentals for Suven Life Sciences Ltd

Suven Life Sciences Ltd
NSE: SUVEN
Share Price
Market Price of Suven Life Sciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 117.45 |
20 Feb 2025 | 118.4 |
19 Feb 2025 | 116.35 |
18 Feb 2025 | 111.45 |
17 Feb 2025 | 115.25 |
14 Feb 2025 | 116.25 |
13 Feb 2025 | 124.15 |
12 Feb 2025 | 123.9 |
11 Feb 2025 | 120.25 |
10 Feb 2025 | 130 |
SWOT Analysis Of Suven Life Sciences Ltd
BlinkX Score for Suven Life Sciences Ltd
Asset Value vs Market Value of Suven Life Sciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Suven Life Sciences Ltd | 2561 | - |
Max Healthcare Institute Ltd | 98177 | 92.6 |
Apollo Hospitals Enterprise Ltd | 90854 | 69.3 |
Fortis Healthcare Ltd | 46713 | 59.2 |
Global Health Ltd | 33160 | 65.4 |
Syngene International Ltd | 28739 | 60.2 |
Company | |
---|---|
Suven Life Sciences Ltd | 2561 |
Max Healthcare Institute Ltd | 98177 |
Apollo Hospitals Enterprise Ltd | 90854 |
Fortis Healthcare Ltd | 46713 |
Global Health Ltd | 33160 |
Syngene International Ltd | 28739 |
PE Ratio of Suven Life Sciences Ltd Explained
₹2561
Market cap
₹-143
Earnings
0.0X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Healthcare Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Suven Life Sciences Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Suven Life Sciences Ltd
Historical Revenue, EBITDA and Net Profit of Suven Life Sciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Suven Life Sciences Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Suven Life Sciences Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Suven Life Sciences Ltd
About Suven Life Sciences Ltd
- Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989.
- The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
- Promoted by Sudharani Jasti and Venkateswarlu Jasti, the Company began operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
- Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.
Suven Life Sciences Ltd News Hub
Indices trade with major losses; media shares under pressure
The headline equity benchmarks traded with deep cuts in the mid-afternoon trade. The decline was dri
Read more
05 Aug 24
Suven Life Sciences reports consolidated net loss of Rs 28.04 crore in the June 2024 quarter
Net Loss of Suven Life Sciences reported to Rs 28.04 crore in the quarter ended June 2024 as against
Read more
05 Aug 24
Suven Life hits lower circuit as Q1 net loss widens to Rs 28 cr
Consolidated net sales slipped 73.42% year on year (YoY) to Rs 1.01 crore in the quarter ended 30 Ju
Read more
05 Aug 24
Suven Life Sciences announces board meeting date
Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 29 October 2024.
Read more
21 Oct 24